Response by Kapplinger et al to Letter Regarding Article, "Yield of the RYR2 Genetic Test in Suspected Catecholaminergic Polymorphic Ventricular Tachycardia and Implications for Test Interpretation".
Jamie D Kapplinger, David J Tester, Michael J Ackerman
Journal: Circulation. Genomic and precision medicine
2019;11(5):e002176
Address:
Mayo Clinic School of Medicine (J.D.K., M.J.A.).; Medical Scientist Training Program (J.D.K.).; Mayo Clinic Graduate School of Biomedical Sciences, Department of Molecular Pharmacology and Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory (J.D.K., D.J.T., M.J.A.).; Division of Heart Rhythm Services, Department of Cardiovascular Medicine (D.J.T., M.J.A.).; Division of Pediatric Cardiology, Department of Pediatrics (M.J.A.), Mayo Clinic, Rochester, MN.
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.